GlassScriptPhysician profile
Claire Joseph
NPI 1811990112
$576.30
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $440 · 2020: $136.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $111.68 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $90.08 | 2019-2020 | |
| Genzyme Corporation | $86.86 | 2019-2020 | |
| Amgen INC. | $62.57 | 2019 | |
| Allergan, INC. | $36.67 | 2019-2020 | |
| Csl Behring | $31.55 | 2019 | |
| Acadia Pharmaceuticals INC | $26.56 | 2019 | |
| Amarin Pharma, INC. | $24.57 | 2019-2020 | |
| Akcea Therapeutics, INC. | $23.61 | 2019 | |
| Daiichi Sankyo INC. | $20.47 | 2020 | |
| Lundbeck LLC | $19.89 | 2019 | |
| Alnylam Pharmaceuticals INC. | $16.47 | 2019 | |
| Supernus Pharmaceuticals, INC. | $13.85 | 2020 | |
| Amneal Pharmaceuticals LLC | $11.47 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Claire Joseph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.